Literature DB >> 14669951

The cryptic self in thyroid autoimmunity: the paradigm of thyroglobulin.

George Carayanniotis1.   

Abstract

Recent studies have increased the number of known thyroiditogenic sites in thyroglobulin (Tg) to thirteen. These sites contain T-cell epitopes and are scattered throughout Tg, with nine of them localized toward the carboxyl terminal third of the molecule. So far, no pathogenic determinant has been found to be dominant, i.e. to be readily and consistently generated in extrathyroidal antigen-presenting cells (APC) following processing of intact Tg in vivo and in vitro. However, certain conditions, such as internalization of Tg-antibody complexes or enhanced iodination of Tg, have been described to promote generation of cryptic pathogenic peptides in APC, in vitro. These findings support the view that post-translational events can "unmask the cryptic self' and suggest mechanisms that may contribute to the pathogenesis of thyroiditis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669951     DOI: 10.1080/08916930310001602975

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  11 in total

1.  Detection of thyroglobulin mRNA as truncated isoform(s) in mouse thymus.

Authors:  Haiyan S Li; George Carayanniotis
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

2.  Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis.

Authors:  H S Li; P Verginis; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Thyroxine-binding antibodies inhibit T cell recognition of a pathogenic thyroglobulin epitope.

Authors:  Yang D Dai; Petros Eliades; Karen A Carayanniotis; Daniel J McCormick; Yi-Chi M Kong; Vassiliki Magafa; Paul Cordopatis; Peggy Lymberi; George Carayanniotis
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

4.  Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women.

Authors:  Liang-Miao Chen; Qian Zhang; Guang-Xin Si; Qing-Shou Chen; En-ling Ye; Le-Chu Yu; Meng-Meng Peng; Hong Yang; Wen-Jun Du; Chi Zhang; Xue-Mian Lu
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

5.  Variable influences of iodine on the T-cell recognition of a single thyroglobulin epitope.

Authors:  Hong Y Jiang; Haiyan S Li; Karen Carayanniotis; George Carayanniotis
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

Review 6.  Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?

Authors:  Fabrizio Gentile; Marisa Conte; Silvestro Formisano
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

7.  Pathogenicity of a human thyroglobulin peptide (2340-2359) in mice with high or low genetic susceptibility to thyroiditis.

Authors:  Aikaterini Hatzioannou; Elisavet Liakata; Evangelos Karras; Apollon Thrasyvoulides; Maria Alevizaki; Peggy Lymberi
Journal:  Immunology       Date:  2007-06-29       Impact factor: 7.397

Review 8.  Iodoprophylaxis and thyroid autoimmunity: an update.

Authors:  Claudia Teti; Marta Panciroli; Elena Nazzari; Giampaola Pesce; Stefano Mariotti; Antonella Olivieri; Marcello Bagnasco
Journal:  Immunol Res       Date:  2021-04-29       Impact factor: 2.829

Review 9.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 10.  Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress.

Authors:  Safikur Rahman; Ayyagari Archana; Arif Tasleem Jan; Durgashree Dutta; Abhishek Shankar; Jihoe Kim; Rinki Minakshi
Journal:  Front Immunol       Date:  2019-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.